BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27560782)

  • 1. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections.
    Toro JF; Salgado DM; Vega R; Rodríguez JA; Rodríguez LS; Angel J; Franco MA; Greenberg HB; Narváez CF
    PLoS One; 2016; 11(8):e0161795. PubMed ID: 27560782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of the Magnitude, Breadth and Depth of the Antibody Response at Epitope Level Following Dengue Infection.
    Falconi-Agapito F; Kerkhof K; Merino X; Michiels J; Van Esbroeck M; Bartholomeeusen K; Talledo M; Ariën KK
    Front Immunol; 2021; 12():686691. PubMed ID: 34290707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Dengue Virus-Specific IgM and IgG Antibodies through Peptide Sequences of Envelope and NS1 Proteins for Serological Identification.
    Nagar PK; Savargaonkar D; Anvikar AR
    J Immunol Res; 2020; 2020():1820325. PubMed ID: 32832567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.
    Andrade P; Narvekar P; Montoya M; Michlmayr D; Balmaseda A; Coloma J; Harris E
    J Infect Dis; 2020 Jul; 222(4):590-600. PubMed ID: 32193549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay.
    Hadjilaou A; Green AM; Coloma J; Harris E
    J Immunol; 2015 Oct; 195(7):3490-6. PubMed ID: 26320246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced performance of an innovative dengue IgG/IgM rapid diagnostic test using an anti-dengue EDI monoclonal antibody and dengue virus antigen.
    Lee J; Kim YE; Kim HY; Sinniah M; Chong CK; Song HO
    Sci Rep; 2015 Dec; 5():18077. PubMed ID: 26655854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of dengue fever in Khyber Pakhtunkhawa, Pakistan.
    Ali A; Rehman HU; Nisar M; Rafique S; Ali S; Hussain A; Nausheen ; Idrees M; Sabri S; Zada H; Hussain S
    Int J Infect Dis; 2013 Jul; 17(7):e518-23. PubMed ID: 23523057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant secondary dengue infection among Vietnamese adults mostly without warning signs and severe disease.
    Lytton SD; Nematollahi G; van Tong H; Xuan Anh C; Hung HV; Hoan NX; Diez G; Schumacher T; Landt O; Melchior W; Fuchs D; Toan NL; Velavan TP; Song LH
    Int J Infect Dis; 2020 Nov; 100():316-323. PubMed ID: 32896661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever.
    Bachal R; Alagarasu K; Singh A; Salunke A; Shah P; Cecilia D
    Arch Virol; 2015 Oct; 160(10):2435-43. PubMed ID: 26175069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Potent Virus-Specific Antibody-Secreting Cell Response to Acute Enterovirus 71 Infection in Children.
    Huang KY; Lin JJ; Chiu CH; Yang S; Tsao KC; Huang YC; Lin TY
    J Infect Dis; 2015 Sep; 212(5):808-17. PubMed ID: 25712974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods to discriminate primary from secondary dengue during acute symptomatic infection.
    Nguyen THT; Clapham HE; Phung KL; Nguyen TK; DInh TT; Nguyen THQ; Tran VN; Whitehead S; Simmons C; Wolbers M; Wills B
    BMC Infect Dis; 2018 Aug; 18(1):375. PubMed ID: 30086716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
    Godoy-Lozano EE; Téllez-Sosa J; Sánchez-González G; Sámano-Sánchez H; Aguilar-Salgado A; Salinas-Rodríguez A; Cortina-Ceballos B; Vivanco-Cid H; Hernández-Flores K; Pfaff JM; Kahle KM; Doranz BJ; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Rodriguez MH; Martínez-Barnetche J
    Genome Med; 2016 Feb; 8(1):23. PubMed ID: 26917418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.
    Hapugoda MD; Batra G; Abeyewickreme W; Swaminathan S; Khanna N
    Clin Vaccine Immunol; 2007 Nov; 14(11):1505-14. PubMed ID: 17898184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell responses during primary and secondary dengue virus infections in humans.
    Mathew A; West K; Kalayanarooj S; Gibbons RV; Srikiatkhachorn A; Green S; Libraty D; Jaiswal S; Rothman AL
    J Infect Dis; 2011 Nov; 204(10):1514-22. PubMed ID: 21930609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.
    Sasaki S; Jaimes MC; Holmes TH; Dekker CL; Mahmood K; Kemble GW; Arvin AM; Greenberg HB
    J Virol; 2007 Jan; 81(1):215-28. PubMed ID: 17050593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.
    Vivanco-Cid H; Maldonado-Rentería MJ; Sánchez-Vargas LA; Izaguirre-Hernández IY; Hernández-Flores KG; Remes-Ruiz R
    Immunol Lett; 2014 Sep; 161(1):89-95. PubMed ID: 24858204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar.
    Ngwe Tun MM; Thant KZ; Inoue S; Kurosawa Y; Lwin YY; Lin S; Aye KT; Thet Khin P; Myint T; Htwe K; Mapua CA; Natividad FF; Hirayama K; Morita K
    J Med Virol; 2013 Jul; 85(7):1258-66. PubMed ID: 23595687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
    Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
    Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G antibody response in children and adults with acute dengue 3 infection.
    Vazquez S; Acosta N; Ruiz D; Calzada N; Alvarez AM; Guzman MG
    J Virol Methods; 2009 Jul; 159(1):6-9. PubMed ID: 19442837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.